COVID-19: pathogenesis

Longest COVID-19 infection lasted 505 days in an immunocompromised person in London

Variation in ACE2 levels are not related to outcomes from COVID-19

No differences in outcomes among women with and without HIV with high-risk pregnancies and COVID-19

Correlation between COVID-19 severity and immune responses after six months

Durable antibody responses 9 months after exposure irrespective of symptoms: broader vaccine coverage still needed to reach herd immunity

Long COVID: studies reporting on long-term follow up on COVID-19

High rates of undocumented COVID-19 mortality in Zambia without testing challenges the idea that Africa has been spared

UK variant B.1.1.7 linked to higher risk of death and hospitalisation from COVID-19

Very low-level HIV viraemia might continue after COVID-19

Webcasts of two-day US Workshop on Long COVID (PASC) now online

Most people hospitialised with COVID-19 have at least one symptom after 6 months: Wuhan cohort

Serious complications commonly reported three months after recovery from COVID-19

Long COVID: Mild infection and sustained long-term complications

Higher mortality from COVID-19 in London study in Asian or Black compared to white participants

UK study reports antibody responses linked to more severe COVID-19 in higher risk populations

Changes in taste and smell as symptoms of COVID-19

Low CD4s and CD8s – but not viral genetics – predict COVID-19 progression

Autopsies show how COVID-19 damages lungs more than flu

Potential for CoV-2 to be widely distributed in cells throughout the body

Debate over development of pathogenic strains of CoV-2

A clinical-therapeutic staging proposal for COVID-19

Clinical outcomes of adult inpatients with COVID-19

Clinical characteristics of COVID-19 in China

COVID-19 is associated with significant drops in CD4 count

CoV-2 viral load in throat saliva samples correlates with clinical outcomes from COVID-19

CROI 2020: Special session on COVID-19